Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic.

Inactivated influenza virus vaccines: the future of TIV and QIV. Curr Opin Virol (2017) 0.77

Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ (2009) 3.22

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog (2010) 3.08

Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.03

Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One (2010) 2.16

Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec (2010) 1.54

Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc (2010) 1.32

Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun (2010) 1.29

Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect (2010) 1.16

Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J Hosp Infect (2011) 1.07

Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United States. Clin Infect Dis (2011) 1.01

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci Transl Med (2013) 0.99

Pandemic (H1N1) 2009 risk for frontline health care workers. Emerg Infect Dis (2011) 0.97

Control of influenza in healthcare settings: early lessons from the 2009 pandemic. Curr Opin Infect Dis (2010) 0.94

Healthcare personnel and nosocomial transmission of pandemic 2009 influenza. Crit Care Med (2010) 0.89

Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe, Japan. J Infect (2011) 0.86

Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic. J Environ Public Health (2011) 0.82

[Pandemic influenza one year after the first wave: what did we learn?]. Rev Chilena Infectol (2010) 0.81

H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic. Pediatr Emerg Care (2011) 0.81

Seropositivity for influenza A(H1N1)pdm09 virus among frontline health care personnel. Emerg Infect Dis (2013) 0.81

Seroprevalence of antibodies to the influenza A (H1N1) virus among healthcare workers prior to the 2009 pandemic peak. Enferm Infecc Microbiol Clin (2012) 0.79

Pandemic 2009 influenza A (H1N1) virus among Japanese healthcare workers: seroprevalence and risk factors. Infect Control Hosp Epidemiol (2011) 0.79

Longitudinal seroepidemiologic study of the 2009 pandemic influenza A (H1N1) infection among health care workers in a children's hospital. BMC Infect Dis (2012) 0.79

Seroprevalence of 2009 H1N1 virus infection and self-reported infection control practices among healthcare professionals following the first outbreak in Bangkok, Thailand. Influenza Other Respir Viruses (2012) 0.78